Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
Adrian Wildfire
Advertisement
Adrian Wildfire is project director, Infectious Diseases &Viral Challenge Unit, SGS Life SciencesâClinical Research.
Articles by Adrian Wildfire
Advertisement
Latest Updated Articles
Using Human Challenge Trials to Develop Flu VaccinesNovember 15th 2017
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
5